The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
Open accessAbstract
The NF-kappa B transcription factor complex is comprised of two subunits, p50 and p65, that share significant homology to the rel oncogene. We have isolated a cDNA encoding a novel 66-kD rel-related protein, designated I-Rel. Unlike other rel-related proteins, I-Rel does not interact with DNA. I-Rel forms heterodimers with p50, however, and greatly attenuates its DNA-binding activity--an effect probably resulting from the presence of a domain inhibitory to DNA binding present within the 121 amino-terminal residues of I-Rel. In contrast, I-Rel does not associate with p65. Transfection experiments demonstrate that I-Rel suppresses NF-kappa B-induced transcription, probably through its association with p50. Expression of I-Rel mRNA is induced by mitogenic stimulation and accumulates after the appearance of p50 transcripts. Our findings suggest that p50 and I-Rel are components of a feedback pathway where expression of I-Rel may modulate indirectly the expression of genes responsive to the NF-kappa B transcription factor complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Cited by
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., & Dalton, T. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00310-x · Cited by 1,004
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
Grilli, M., Chiu, J. J.-S., & Lenardo, M. J. (1993) · International Review of Cytology · doi:10.1016/s0074-7696(08)61873-2 · Cited by 936
Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A., & Baldwin, A. S. (1992) · Genes & Development · doi:10.1101/gad.6.10.1899 · Cited by 718
Self-citationMutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.
Brown, K., Park, S., Kanno, T., Franzoso, G., & Siebenlist, U. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2532 · Cited by 621
Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., & Bensi, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6231 · Cited by 585
Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2455 · Cited by 567
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517
“1RELA is a known suppressor of NF- Binduced transcription; its down-regulation may underscore the importance of hyperactivation of NF- Bmediated signaling pathways in AD brain (Ruben et al., 1992; O’Neil and Kaltschmidt 1997; Lukiw and Bazan, 1998; Mattson et al., 2000).”
BackgroundBours, V (1993) · Cell · doi:10.1016/0092-8674(93)90401-b · Cited by 495
NF-κB Subunit-Specific Regulation of the Interleukin-8 Promoter
Kunsch, C., & Rosen, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6137-6146.1993 · Cited by 493
Self-citationKunsch, C., Ruben, S. M., & Rosen, C. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4412-4421.1992 · Cited by 488
Self-citationA cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., & Nabel, G. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06029.x · Cited by 484
The inducible transcription factor NF-κ B: structure-function relationship of its protein subunits
Grimm, S., & Baeuerle, P. A. (1993) · Biochemical Journal · doi:10.1042/bj2900297 · Cited by 429
Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.
Zabel, U., Henkel, T., Silva, M. S., & Baeuerle, P. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05646.x · Cited by 319
In vivo control of NF-kappa B activation by I kappa B alpha.
Rice, N. R., & Ernst, M. K. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06157.x · Cited by 308
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
La Rosa, F. A., Pierce, J. W., & Sonenshein, G. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1039 · Cited by 283
Ganchi, P. A., Sun, S. C., Greene, W. C., & Ballard, D. W. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.12.1339 · Cited by 257
The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation
Wulczyn, F. G., Krappmann, D., & Scheidereit, C. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050078 · Cited by 256
Davis, T. A., Saini, A. A., Blair, P. J., Levine, B. L., Craighead, N., Harlan, D. M., June, C. H., & Lee, K. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3689 · Cited by 70
Metadata
- Authors
- Ruben, S. M., Klement, J. F., Coleman, T. A., Maher, M., Chen, C. H., & Rosen, C. A.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1992-05
- Volume
- 6
- Issue
- 5
- Pages
- 745-760
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2170540477
- Cited by
- 164
- References
- 1
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.